UHS:NYE-Universal Health Services Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 174.14

Change

0.00 (0.00)%

Market Cap

USD 11.70B

Volume

1.40M

Analyst Target

USD 129.60
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Bullish

About

Universal Health Services Inc through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
UHS VTI
  • VTI
Relative Returns (From:    To: 2025-03-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+5.05 (+1.54%)

USD 79.32B
THC Tenet Healthcare Corporation

+6.29 (+5.11%)

USD 12.13B
DVA DaVita HealthCare Partners Inc

+2.26 (+1.53%)

USD 11.92B
EHC Encompass Health Corp

+2.86 (+2.95%)

USD 10.00B
CHE Chemed Corp

+12.78 (+2.15%)

USD 8.72B
CON Concentra Group Holdings Paren..

+0.67 (+3.22%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.07 (+0.53%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.74 (+0.82%)

USD 1.90B
AGL agilon health Inc

-0.05 (-1.10%)

USD 1.67B
GRDN Guardian Pharmacy Services, In..

+0.05 (+0.23%)

USD 1.25B

ETFs Containing UHS

XLVE:CA 1.94 % 0.00 %

N/A

N/A
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

-0.15 (0%)

CAD 0.01B
FXH First Trust Health Care A.. 0.00 % 0.63 %

+1.46 (+0%)

USD 1.01B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.94% 41% F 35% F
Dividend Return 0.11% 40% F 2% F
Total Return -2.83% 41% F 35% F
Trailing 12 Months  
Capital Gain -3.52% 55% F 32% F
Dividend Return 0.33% 20% F 4% F
Total Return -3.19% 55% F 27% F
Trailing 5 Years  
Capital Gain 142.40% 71% C- 71% C-
Dividend Return 4.45% 25% F 7% C-
Total Return 146.85% 71% C- 65% D
Average Annual (5 Year Horizon)  
Capital Gain 13.33% 50% F 73% C
Dividend Return 13.86% 59% D- 70% C-
Total Return 0.53% 30% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 30.21% 73% C 34% F
Risk Adjusted Return 45.86% 73% C 60% D-
Market Capitalization 11.70B 86% B+ 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.30 69% 74%
Price/Book Ratio 1.68 70% 47%
Price / Cash Flow Ratio 5.43 62% 59%
Price/Free Cash Flow Ratio 7.08 75% 62%
Management Effectiveness  
Return on Equity 17.94% 65% 81%
Return on Invested Capital 12.07% 73% 74%
Return on Assets 7.41% 84% 89%
Debt to Equity Ratio 66.15% 60% 52%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.